KMDerma
ActiveSummary
KMDerma has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €236,492 and a net result of €127,759. Its solvency ranks better than 90% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- KMDerma
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, filialen,administratieve zetels,agentschappen en bijkantoren in België of buitenland bij eenvoudig besluit bestuursorgaan” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Artikel 11. Bevoegdheden van het bestuursorgaan Als er slechts één bestuurder is, is het geheel van de bestuursbevoegdheden aan hem…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Bestuursorgaan, artsen-aandeelhouders” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Bij aangetekende brief aan bestuursorgaan met naam voornamen beroep specialisatie woonplaats voorgestelde overnemer aantal aandelen geboden…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Fourth Thursday of June at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vereist voor statutenwijziging, algemene vergadering” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Algemene vergadering te allen tijde bij gewone meerderheid, behoudens toepassing artikel 2:80 WVV” (deed in Dutch)